Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model.
Conclusions: These results suggest that the IL-17-leptin/adiponectin axis plays a key role in airway inflammation in obesity-related asthma. Our findings suggest a potential new treatment for IL-17 as a target that may benefit obesity-related asthma patients who respond poorly to typical asthma medications.
PMID: 29665658 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Liang L, Hur J, Kang JY, Rhee CK, Kim YK, Lee SY Tags: Korean J Intern Med Source Type: research
More News: Allergy & Immunology | Asthma | Diets | Eating Disorders & Weight Management | High Fat | Internal Medicine | Nutrition | Obesity | Pravastatin | Statin Therapy | Study